High-Purity Therapeutic Peptides, Solid-Phase Peptide Synthesis (SPPS), MINSA Regulatory Compliance, and Ultra-Low Temperature Cold-Chain Supply Infrastructure for Latin America.
Fully compliant with international cGMP standards and ready for MINSA registration, backed by full Drug Master File (DMF) technical packages.
Synthetic GLP-1 receptor agonist designed for metabolic disorders, blood sugar control, and obesity management. Purity ≥99.0% by RP-HPLC.
View Product Details →
Synthetic vasopressin analogue supplying potent antidiuretic regulation. Ultra-low endotoxin levels tailored for parenteral formulations.
View Product Details →
Cyclic heptapeptide platelet aggregation inhibitor targeted for emergency acute coronary syndromes and percutaneous coronary intervention.
View Product Details →
Systemic vasoconstrictor prodrug crucial for treating bleeding esophageal varices and hepatorenal syndrome type 1 with high clinical efficacy.
View Product Details →Panama has rapidly emerged as the definitive logistical and financial gateway for pharmaceutical distribution across Central America, the Caribbean, and northern South America. Driven by the expansion of the Colon Free Zone (Zona Libre de Colón) and state-of-the-art cold-chain logistics hubs adjacent to Tocumen International Airport, local biopharmaceutical distributors and generic formulation manufacturers require robust, ultra-pure Active Pharmaceutical Ingredients (APIs).
The healthcare burden in Panama and broader LATAM regions has seen a sharp increase in metabolic syndromes, Type-2 Diabetes, cardiovascular events, and oncology indications. Consequently, demand for complex therapeutic peptides—such as GLP-1 receptor agonists (Liraglutide, Semaglutide, Tirzepatide) and hemostatic peptides (Terlipressin, Carbetocin)—has reached unprecedented levels. Importers must navigate stringent compliance standards set by the MINSA (Ministerio de Salud de Panamá), demanding flawless traceability, cGMP validation, and zero-defect cold-chain integrity.
Our complete analytical dossiers include full structure elucidation (NMR, MS, HRMS), elemental analysis, residual solvent profiles (ICH Q3C), heavy metals, and batch stability data under Zone IVb conditions (30°C / 75% RH) to meet Panama's tropical climate regulatory metrics.
Peptide molecules are highly sensitive to thermal degradation. We employ specialized phase-change material (PCM) validated packaging with continuous IoT temperature logging to ensure -20°C and 2-8°C integrity throughout transit from factory floor to Panama City depositories.
Transitioning from traditional Liquid-Phase Synthesis (LPPS) to high-yield Solid-Phase Peptide Synthesis (SPPS) and green peptide chemical engineering.
By utilizing Fmoc/tBu protective group strategies coupled with high-efficiency resins ( CTC, Rink Amide), we achieve sub-gram to multikilogram production runs with raw crude purity surpassing 85-90% before purification.
Industrial scale preparative Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) utilizing dynamic axial compression (DAC) columns guarantees consistent batch-to-batch chemical purity exceeding 99.0% with individual impurities held strictly <0.5%.
Enclosed continuous cleavage technology minimizes trifluoroacetic acid (TFA) environmental exposure, combined with optimized freeze-drying lyophilization cycles to yield stable, light powder APIs with rapid reconstitution characteristics.
| Peptide API Category | Synthesis Technology | Typical Purity (HPLC) | Bacterial Endotoxin | Primary Clinical Application in Panama |
|---|---|---|---|---|
| GLP-1 Analogues (Semaglutide / Liraglutide) | Hybrid SPPS / Recombinant + Chemical Modification | ≥ 99.2% | < 0.05 EU/mg | Type 2 Diabetes Mellitus & Chronic Weight Management |
| Vasoconstrictors & Hemostatics (Terlipressin / Eptifibatide) | Solid-Phase Peptide Synthesis (SPPS) | ≥ 99.0% | < 0.01 EU/mg | Emergency Care: Variceal Bleeding & Acute Coronary Syndrome |
| Reproductive Health (Atosiban / Cetrorelix / Ganirelix) | Fmoc Solid-Phase Synthesis | ≥ 98.5% | < 0.02 EU/mg | Obstetrics & IVF Assisted Reproductive Technology |
| Metabolic & Endocrine (Desmopressin / Teriparatide) | LPPS / SPPS Automated Lines | ≥ 99.0% | < 0.01 EU/mg | Central Diabetes Insipidus & Severe Osteoporosis |
Our strategic manufacturing base leverages state-of-the-art Industry 4.0 automation, connecting real-time digital synthesis tracking, automated raw material dispensing, and computer-controlled crystallization processes. Spanning over 250,000 square meters of standardized international cGMP facilities, we eliminate the traditional bottlenecks associated with peptide synthesis.
For Panamanian pharmaceutical exporters, distributors, and contract manufacturing organizations (CMOs), partnering directly with our primary facility delivers unparalleled economic efficiency without sacrificing quality:
We understand that supply chain interruptions can stall local drug registrations and market availability in Panama. Our strategic inventory reserves and fast-track air freight protocols ensure uninterrupted deliverability.
Creating opportunities by connecting global biopharmaceutical markets with guaranteed high-purity products and specialized technical support.
Our main services focus on supplying Peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
End-to-end analytical assay development, impurity synthesis, peptide sequence optimization, and formulation stability testing.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
View Details & Contact Representatives
Explore our recent whitepapers, technical breakthroughs, and peptide product analysis.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Developed through neuropharmacological research...
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and research organizations...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair and gastrointestinal protection...
View Details
With continuous development in neuroscience, Semax, a synthetic peptide derived from an ACTH fragment, has attracted attention among researchers due to its unique molecular profile...
View Details
SS-31 API, also known as Elamipretide, MTP-131, and Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane...
View DetailsAddressing key regulatory, logistical, and technical queries for importing Peptide APIs into Panama.
We supply full regulatory documentation required by Panama's Ministerio de Salud (MINSA), including cGMP certificates, Drug Master Files (DMF in eCTD format), Certificate of Analysis (CoA), Stability Data (Zone IVb standard), Residual Solvent Reports, and BSE/TSE-Free statements.
All temperature-sensitive peptides are shipped using validated insulated shippers equipped with Phase-Change Materials (PCM) or dry ice, maintaining -20°C or 2-8°C conditions for up to 120 hours. Continuous calibrated temperature data loggers accompany every shipment to guarantee zero thermal excursion upon arrival at Tocumen Airport or Colon Free Zone.
Our GLP-1 receptor agonist APIs are purified using preparative RP-HPLC to achieve minimum purity levels of ≥99.0% by peak area, with single maximum impurity levels strictly held under 0.5% and low endotoxin levels (<0.05 EU/mg), conforming to USP/EP monographs.
Yes, beyond our commercial API portfolio, we offer custom synthesis of linear, cyclic, and modified peptides (phosphorylation, acetylation, pegylation, fluorophore labeling) ranging from milligram analytical scale to kilogram production runs with custom purification parameters.
All products are manufactured under cGMP standards with global shipping coverage, including Panama and surrounding LATAM regions.
Recombinant/synthetic PTH fragment derivative for bone formation stimulation and severe postmenopausal osteoporosis therapies.
View Product Details →
Synthetic peptide oxytocin antagonist designed to inhibit spontaneous preterm labor contractions with maximum uterine selectivity.
View Product Details →
Long-acting synthetic oxytocin analogue indicated for the prevention of uterine atony and postpartum hemorrhage following cesarean section.
View Product Details →
Synthetic GnRH antagonist utilized in controlled ovarian stimulation programs for assisted reproductive technologies (ART).
View Product Details →
Potent decapeptide GnRH antagonist preventing premature luteinizing hormone (LH) surges in women undergoing fertility treatments.
View Product Details →
Guanylate cyclase-C receptor agonist targeted for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation.
View Product Details →
High purity long-acting GLP-1 analogue encouraging glycemic control and cardiovascular risk reduction in diabetic patients.
View Product Details →
Synthetic GnRH agonist for prostate cancer, endometriosis, and uterine fibroids therapy. Available in micronized powder form.
View Product Details →
Ultra-pure research and commercial grade Semaglutide peptide raw API. Conforms with USP monograph standards with high stability.
View Product Details →
Dual GIP and GLP-1 receptor agonist peptide API delivering unmatched potency in metabolic syndrome and obesity therapeutic trials.
View Product Details →
Synthetic calcimimetic D-amino acid peptide agonist targeting calcium-sensing receptors for hyperparathyroidism treatment.
View Product Details →
Novel long-acting amylin analogue peptide under clinical development for synergistic co-formulation with GLP-1 receptor agonists.
View Product Details →Contact our regulatory specialists and biopharmaceutical engineers today to request technical dossiers, cGMP certificates, and competitive volume pricing.
